1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allergol. 1967. 16:178–222.
2. Freeman AF, Shulman ST. Recent developments in Kawasaki disease. Curr Opin Infect Dis. 2001. 14:357–361.
Article
3. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, et al. Selective expansion of T cells expressing T-Cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A. 1992. 89:4066–4070.
Article
4. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993. 342:1385–1388.
Article
5. Rowley AH, Eckerley CA, Jäck HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol. 1997. 159:5946–5955.
6. Andersson U. Development of B lymphocyte function in childhood. Acta Paediatr Ascand. 1985. 74:568–573.
Article
7. Andersson U, Bird AG, Britton BS, Palacios R. Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev. 1981. 57:1–38.
Article
8. Council on Cardiovascular Disease in the Young. Committee on Rheumatic Fever, and Kawasaki Disease. American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation. 2001. 103:335–336.
9. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol. 1995. 155:190–202.
10. Meissner HC, Leung DY. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatr Infect Dis J. 2000. 19:91–94.
Article
11. Rowley AH. The etiology of Kawasaki disease: superantigen or conventional antigen? Pediatr Infect Dis J. 1999. 18:69–70.
Article
12. Leucht S, Uttenreuther-Fischer MM, Gaedicke G, Fischer P. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy. Clin Immunol. 2001. 99:18–29.
Article
13. Duong TT, Silverman ED, Bissessar MV, Yeung RS. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. Int Immunol. 2003. 15:79–89.
Article
14. Choi IH, Chwae YJ, Shim WS, Kim DS, Kwon DH, Kim JD, et al. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol. 1997. 159:481–486.
15. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol. 2001. 166:1334–1343.
Article
16. Rowley AH, Baker SC, Orenstein JM, Shulman ST. Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008. 6:394–401.
Article
17. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol. 1988. 15:1243–1249.
18. Leung DY, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, et al. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med. 1986. 164:1958–1972.
Article
19. Leung DY. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Acta Paediatr Jpn. 1991. 33:739–744.
Article
20. Lee TJ, Kim KH, Chun JK, Kim DS. Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease. Yonsei Med J. 2008. 49:714–718.
Article
21. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH. The structural basis of germline-encoded V
H3 immunoglobulin binding to staphylococcal protein A. J Exp Med. 1993. 178:331–336.
Article
22. Silverman GJ. Unconventional B-cell antigens and human immune repertoires. Ann N Y Acad Sci. 1995. 764:342–355.
23. Jukes TH, King JL. Evolutionary nucleotide replacements in DNA. Nature. 1979. 281:605–606.
Article
24. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL, Weigert MG. The role of clonal selection and somatic mutation in autoimmunity. Nature. 1987. 328:805–811.
Article
25. Shlomchik MJ, Nemazee DA, Sato VL, Van Snick J, Carson DA, Weigert MG. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med. 1986. 164:407–427.
Article